Neo Ivy Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1K | Buy |
+192
| New | +$29.1K | 0.01% | 317 |
|
|
2025
Q1 | – | Sell |
-1,956
| Closed | -$361K | – | 314 |
|
|
2024
Q4 | $361K | Sell |
1,956
-2,946
| -60% | -$544K | 0.07% | 180 |
|
|
2024
Q3 | $966K | Buy |
+4,902
| New | +$966K | 0.31% | 127 |
|
|
2023
Q4 | – | Sell |
-1,104
| Closed | -$216K | – | 323 |
|
|
2023
Q3 | $216K | Buy |
+1,104
| New | +$216K | 0.09% | 223 |
|
|
2022
Q4 | $465K | Buy |
+2,136
| New | +$465K | 0.31% | 164 |
|